LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.

Niu K, Qu S, Zhang X, Dai J, Wang J, Nie Y, Zhang H, Tao K, Song W.

DOI: 10.1155/2021/3031482
Published: 2021-10-07
Container: Evid Based Complement Alternat Med
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2021/3031482,
  title = {LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.},
  author = {Niu K and  Qu S and  Zhang X and  Dai J and  Wang J and  Nie Y and  Zhang H and  Tao K and  Song W.},
  year = {2021},
  journal = {Evid Based Complement Alternat Med},
  doi = {10.1155/2021/3031482},
  url = {https://doi.org/10.1155/2021/3031482}
}

RIS

TY  - JOUR
TI  - LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.
AU  - Niu K
AU  -  Qu S
AU  -  Zhang X
AU  -  Dai J
AU  -  Wang J
AU  -  Nie Y
AU  -  Zhang H
AU  -  Tao K
AU  -  Song W.
PY  - 2021
JO  - Evid Based Complement Alternat Med
DO  - 10.1155/2021/3031482
UR  - https://doi.org/10.1155/2021/3031482
ER  -

APA

K, N., S, Q., X, Z., J, D., J, W., Y, N., H, Z., K, T., & W., S. (2021). LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.. Evid Based Complement Alternat Med. https://doi.org/10.1155/2021/3031482

Source records

europe-pmc · retrieved 2026-09-25T07:48:31.792Z